green
Positive treatment
5.6 score
Treatment trajectory · 1999 → 2026 · click a year to view as-of
1999
2012
2026
Top citers, strongest first. 10 distinct citers.
How cited ↗
discussed
Cited "see"
Sharpe v. Cureton
See Cureton v. Sharpe, 528 U.S. 812 , 120 S.Ct. 47 , 145 L.Ed.2d 42 (1999). 21 A jury trial commenced on January 31, 2000, with the jury returning the following verdicts: Sharpe was awarded $2,500 in compensatory damages because Cureton and Ashe had retaliated against him for filing the complaint; however, he suffered no pre-complaint discrimination; W.
cited
Cited "see"
Sharpe v. Cureton
See Cureton v. Sharpe, 528 U.S. 812 , 120 S.Ct. 47 , 145 L.Ed.2d 42 (1999).
discussed
Cited "see"
OXY USA, Inc. v. Babbitt
See Medlock v. Ortho Biotech, Inc., 164 F.3d 545, 556 (10th Cir.) (citing Dole v. United Steelworkers of America, 494 U.S. 26, 41 , 110 S.Ct. 929 , 108 L.Ed.2d 23 (1990)), cert. denied, 528 U.S. 813 , 120 S.Ct. 48 , 145 L.Ed.2d 42 (1999).
cited
Cited "see"
United States v. Frank Dickerson, A.K.A. Lane, A.K.A. Frank Dixon
See City of Tuscaloosa v. Harcros Chems., Inc., 158 F.3d 548 , 556 (11th Cir.1998), cert. denied, 528 U.S. 812 , 120 S.Ct. 309 , 145 L.Ed.2d 42 (1999).
discussed
Cited "see"
Cisneros v. Wilson
(2×)
See Medlock v. Ortho Biotech, Inc., 164 F.3d 545, 550 (10th Cir.), cert denied, — U.S. -, 120 S.Ct. 48 , 145 L.Ed.2d 42 (1999).
discussed
Cited "see"
Febres v. Challenger Caribbean Corp.
See Medlock v. Ortho Biotech, Inc., 164 F.3d 545, 552 (10th Cir.), cert. denied, — U.S. -, 120 S.Ct. 48 , 145 L.Ed.2d 42 (1999); see also United States v. Flores, 968 F.2d 1366, 1367-68 (1st Cir.1992).
discussed
Cited "see"
Blomkest Fertilizer, Inc. v. Potash Corp. of Saskatchewan, Inc.
See City of Tuscaloosa v. Harcros Chems., Inc., 158 F.3d 548 , 570-73 (11th Cir.1998) (incumbency rate on new contracts so high it was inconsistent with independent action), cert. denied, - U.S. -, 120 S.Ct. 309 , 145 L.Ed.2d 42 (1999). .
discussed
Cited "see, e.g."
State v. Marsh and McLennan Companies, Inc.
Kan. 1998); see also Tuscaloosa v. Harcros Chemicals, Inc., 158 F.3d 548, 566-67 (11th Cir. 1998) *476 (statistician’s testimony is admissible as circumstantial evidence to indicate collusive behavior in state’s chlorine marketplace), cert. denied, 528 U.S. 812 , 120 S. Ct. 309 , 145 L.
discussed
Cited "see, e.g."
State v. Peeler
See, e.g., Tuscaloosa v. Harcros Chemicals, Inc., 158 F.3d 548, 559 (11th Cir. 1998) (“[a] statement that merely discloses the existence of a conspiracy to a non-conspirator, that merely ‘spills the beans,’ with no intention of recruiting the [nonconspirator] into the conspiracy does not further the conspiracy”), cert. denied, 528 U.S. 812 , 120 S. Ct. 309 , 145 L.
discussed
Cited "see, e.g."
In re Flat Glass Antitrust Litigation
Indeed, “regression and statistical analysis have been admitted in antitrust cases to prove injury and to determine damages.” Id. (finding use of multiple regression analysis reliable under Rule 702); see also City of Tuscaloosa v. Harcros Chems., Inc., 158 F.3d 548 , 566 (11th Cir.1998) (expert’s compilation of data from business records and analysis with simple arithmetic, algebra, and multiple regression analysis is well-established as a reliable methodology), reh’g en banc denied, 172 F.3d 884 (11th Cir.), and cert. denied, — U.S. -, 120 S.Ct. 309 , 145 L.Ed.2d 42 (1999); Askew v…
Retrieving the full opinion text from the archive…
Industrial Chemicals, Inc.
v.
City of Tuscaloosa and Harcros Chemicals, Inc. v. City of Tuscaloosa
v.
City of Tuscaloosa and Harcros Chemicals, Inc. v. City of Tuscaloosa
No. 98-1807; No. 98-1997.
Supreme Court of the United States.
Oct 4, 1999.
Published
C. A. 11th Cir. Certiorari denied. Reported below: 158 F. 3d 548.